Loading clinical trials...
Loading clinical trials...
Cancer Risk in Solid Organ Transplant Recipients and End-Stage Renal Disease: The Transplant Cancer Match Study
Conditions
Locations
9
United States
California Cancer Registry
Sacramento, California, United States
Colorado Cancer Registry
Denver, Colorado, United States
Connecticut Cancer Registry
Hartford, Connecticut, United States
Georgia Cancer Registry
Atlanta, Georgia, United States
Iowa Cancer Registry
Iowa City, Iowa, United States
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States
Start Date
July 1, 2006
Primary Completion Date
April 22, 2020
Completion Date
April 22, 2020
Last Updated
April 28, 2020
NCT06345508
NCT06066138
NCT05053971
NCT05039801
NCT04550494
NCT06498635
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions